Without exaggeration, we can say that providing citizens with medicines and drugs is an important component of the national security of the state. And pharmaceutical production is the most important socially significant sector of the economy.
Government support
Today, the social importance of products such as pharmaceuticals, the production of which is established in our country, has reached such a level that the government is forced to pay serious attention to projects involving the development of this industry. It should be noted that in recent years a number of policy documents have been adopted to facilitate the organization and development of production, including pharmaceutical substances, but the situation in this area still does not inspire optimism, and here’s why.
Important Industry Features
Pharmaceutical production has its own characteristics. They are presented:
- high technology-intensive products;
- the significant duration of the development process of new medicinal components, as well as corresponding drugs;
- long life cycle of drugs, including all stages - development, production and sales of products;
- the nature and duration of the production cycle required for the production of finished products;
- a wide variety of types of technological processes that are used in such areas as the production of pharmaceutical substances;
- a wide variety of types of raw materials and materials, as well as equipment used in the production cycle;
- multi-stage technological processes.
Investment
From the point of view of a potential investor, pharmaceutical production has a number of distinctive features. And the main negative points that are worth paying attention to are:
- Higher investment attractiveness of finished product production, that is medicines, in comparison with the production of medicinal substances. This trend was formed under the influence of modern economic conditions. An explanation for this fact can be the high material and energy intensity of the production of standardized semi-finished products, which led to a decrease in the profitability of their production, and sometimes to the unprofitability of such production.
- The recent increase in the cost of material resources has caused a significant increase in the cost of substances produced in our country. The consequence of this is that they are affected to a level that exceeds the world level. Such trends have led to the fact that pharmaceutical production has become unable to offer competitive products.
- Providing foreign manufacturers with easy access to the pharmaceutical market of our country. This has created enormous competition for every domestic manufacturer, which in most cases is unable to resist the active expansion of inexpensive substances of low quality into the domestic market.
Main trends in the pharmaceutical market
According to some estimates, the volume of the pharmaceutical market in our country in recent years reaches 1 trillion rubles. At the same time, domestic medicines in the total volume of sold products of this type account for only about 25% in monetary terms and approximately 60% in physical terms.
Hot issues
Today, one of the most pressing issues that worries those interested in the development of domestic pharmaceutical production is the origin of standardized semi-finished products, which are the basis for the production of finished drugs in our state. Unfortunately, the experts’ conclusions do not inspire optimism among domestic producers. Pharmaceutical production of medicinal components is practically undeveloped in our country.
Import of pharmaceutical substances
As for imports, in recent years a situation has arisen where about 80% of the volume of imported pharmaceutical substances in monetary terms is occupied by Germany, France, Italy and China.
It is noteworthy that when considering the physical expression of import volumes, completely different figures are obtained. Thus, its largest share today is China - more than 70% of the total volume. Considering the ratio of specific shares calculated by natural and cost indicators, we can come to the conclusion that substances produced in the named country are characterized by a significantly lower price in comparison with similar products from other countries.
What is imported
Imports include mainly components of very long-known drugs, represented by acetylsalicylic acid, paracetamol, metamizole sodium, metformin, ascorbic acid and others, which are in demand among the population mainly due to their low cost.
It says that the share of what is produced at domestic enterprises is characterized by a negligible figure, 8-9% of the total volume of the pharmaceutical products market.
Conclusions
Probably, the above facts allow us to state the obvious need to restore the production volumes of the products in question. The technology for pharmaceutical production of substances must be restored and applied in full. The development of this area is necessary, first of all, in order to ensure the national security of the state.
Such statements are not empty words at all. Many manufacturers are faced with the fact of providing the domestic economy with substances from foreign suppliers on a residual basis. And this cannot but cause concern.
Over the past 12 months, the pharmaceutical market has shown strong growth, which means that the income of drug manufacturers is growing steadily. Pharmaceuticals are traditionally considered one of the most profitable sectors of the economy.
However, entering this market is not at all easy, because large manufacturers invest billions of dollars in drug development, patenting and sales. Today we present rating of the largest pharmaceutical companies, which presents the world's main players in the medicinal industry.
The company was founded in 1863 in Germany. Bayer produces pharmaceuticals for humans and animals, food additives, and agrochemical fertilizers.
9.Merck & Co
The headquarters of this pharmaceutical company is located in New Jersey, USA. Merck & Co. was founded in 1891 as a subsidiary of the German company Merck KGaA. During the war, the division was confiscated by the American government and turned into an independent company.
8. Abbott Laboratories
The American pharmaceutical company was founded in 1888. And in 2010, Abbott Laboratories' turnover exceeded $35 billion. The company employs more than 91 thousand people.
The Swedish-British company was founded in 1999 by merging the Swedish Astra AB with the British Zeneca. AstraZeneca's turnover is about $25 billion. Today the pharmaceutical company employs more than 50 thousand people.
The French pharmaceutical company produces drugs for various diseases, vaccines, oncology drugs, etc. At the same time, Sanofi is an employer of 112 thousand people.
The Swiss company was founded in 1996. Novartis' subsidiary brands are manufacturers contact lenses Alcon and Ciba Vision, as well as pharmaceutical company Sandoz.
The British pharmaceutical company has offices in 114 countries. GSK operates 24 research and development laboratories. The company's employees are 99 thousand people.
The Swiss holding is active in the market of innovative drugs. F. Hoffmann-La Roche owns three subsidiaries operating in the field of biotechnology. The holding is an employer of 85 thousand people.
The American company was founded in 1849 by two cousins, immigrants from Germany. The company's turnover today exceeds $51 billion. Pfizer employees are 78 thousand people.
Read about the project
When you buy a product or service from someone, you give him money for development, finance him (help). If you don't buy, you don't help (don't finance). By buying Russian goods and services, you help Russian people. This is reasonable for you if you are part of the Russian people.
Dmitry Mezentsev
Subscribe to RUSSIANSOYUZRF @russkii_souz
The information you add must meet our selection criteria
- Russian manufacturers- these are Russian production owners who produce goods on the territory of their country, registered in it and using the labor of Russian workers. Accordingly, they produce Russian goods.
- Russian owners or co-owners of production, using anything foreign in the production process (companions, workers, territory, etc.) are placed in the section “Production with Russian participation" Accordingly, they produce goods with Russian participation.
- Russian sellers- these are Russian entrepreneurs who use the labor of Russian workers and sell Russian goods or goods with Russian participation. If the store has at least one shelf with Russian goods, then the store can be placed in the catalog and advertise these goods.
- Russian services provided by Russian entrepreneurs who use the labor of Russian workers and strive, if possible, to use Russian goods.
Also be sure to check out
JSC "VERTEX" (St. Petersburg)
Production of finished dosage forms and parapharmaceuticals. The company's product portfolio includes more than 200 items. In 2015, a new production site was opened with a design capacity of more than 100 million packages per year.
CJSC "Biocad" (St. Petersburg, Moscow region)
Production of drugs for the treatment of infectious, viral, autoimmune and oncological diseases. Production sites are located in St. Petersburg and the Moscow region. The product portfolio includes 45 items.
Group of companies "GEROPHARM" (St. Petersburg, Moscow region)
Production of biotechnological drugs based on genetic engineering technologies, including insulin analogues, as well as other drugs for the treatment of socially significant diseases. The product portfolio includes 10 drugs.
LLC "NTFF "POLYSAN" (St. Petersburg)
Development and implementation of own-produced drugs into medical practice. The company produces original drugs: Cycloferon, Reamberin, Cytoflavin and Remaxol.
Novartis Neva LLC (St. Petersburg)
The first plant of the Novartis group of companies in Russia. The planned production capacity is 1.5 billion units of solid dosage forms per year.
Grotex LLC (Solopharm) (St. Petersburg)
Specialization in the production of liquid sterile dosage forms. The Solopharm plant was put into operation in 2013. The design capacity is more than 1 billion units of products per year.
CJSC "Active Component" (St. Petersburg)
Production of active pharmaceutical ingredients. More than 30 types of API.
LLC "NPF "KEM" (St. Petersburg)
Industrial chemical synthesis of drug substances. Substances: Dioxidin, Diazolin, Arbidol, Meldonium, Pantogam, Proxadolol, etc.
SKTB "Technolog" (St. Petersburg)
Production of TOC products, composite materials and devices, medicinal substances, polymer compositions
PJSC "Pharmsintez" (St. Petersburg)
Production of fine organic synthesis products (TOS) and active pharmaceutical ingredients (API).
Pharmamed LLC (St. Petersburg)
Release of FPP (Nitroglycerin, Valemidin); Production of active pharmaceutical ingredients (unithiol, iodantipyrine, ethylmethylhydroxypyridine succinate, etc.)
Group of companies Pik-Pharma (St. Petersburg-Belgorod)
Production of substances and finished medicines. The company has three production sites. The product portfolio includes 13 drugs.
MBNPK "Cytomed" (St. Petersburg-Finland)
Production of peptide drugs. Production sites in St. Petersburg and Lappenranta.
OJSC "Pharmaceutical Factory of St. Petersburg" (St. Petersburg)
Development, production and sale of medicinal products from herbal raw materials
Samson-Med LLC (St. Petersburg)
Production is carried out in the following areas: injection forms; infusion solutions; natural hormonal and enzyme preparations.
CJSC "Northern Star" (Len. region, Kuzmolovsky village)
Production of solid dosage forms: tablets and film-coated tablets, hard gelatin capsules. The assortment portfolio consists of about 40 items.
CJSC "Pharmproekt" (St. Petersburg)
Production of finished medicines.
Alkor Bio LLC (St. Petersburg)
Development, production and sale of enzyme immunoassay kits
Pharmacor Production LLC (St. Petersburg)
Production of a wide range of medicines, dietary supplements, as well as packaging production of drugs from leading European companies.
JSC "Medpolymer" (St. Petersburg)
Production of medicines, medical devices and dental products.
LLC "Biotech" (St. Petersburg)
Isolation and purification of recombinant human interleukin-2
OJSC "Pharmstandard" (Moscow)
The company produces more than 200 types of finished medicines. The largest domestic holding
FSUE NPO Microgen, Ministry of Health of the Russian Federation (Moscow)
Development and production of immunobiological, diagnostic and medicinal products
OJSC "Veropharm" (Moscow)
Production of generics, oncology drugs, medical patches.
NPO PETROVAX PHARM (Moscow)
Production of original drugs Polyoxidonium, Longidaza, Grippol.
CJSC PharmFirma Sotex (Moscow)
The company's product portfolio includes 67 medicines, including 28 of its own.
OJSC "Valenta Pharmaceuticals" (Moscow region)
Production of solid dosage forms, as well as production of neurological and antimicrobial drugs
LLC "KRKA-RUS" (Moscow region, Istra)
Production of drugs for the treatment of cardiovascular diseases.
JSC "Akrikhin" (Moscow)
GLS production, the company produces about 150 types of drugs
Alkoy LLC (Moscow)
Development and production of homeopathic medicines, medicinal cosmetics and dietary supplements
CJSC "Partner" (Moscow)
Development and production of immunobiological drugs, dietary supplements and food products for the treatment of dysbacteriosis
CJSC "Moscow Pharmaceutical Factory" (Moscow)
Production of tinctures, extracts, ointments, syrups, homeopathic medicines, medical alcohols...
OJSC "Moskhimfarmpreparaty named after N.A. Semashko" (Moscow)
Production of drugs of various pharmacotherapeutic groups, release of pharmaceutical drugs.
CJSC "EKOlab" (Moscow region, Elektrogorsk)
Production of enzyme immunoassay test systems and other diagnostic MIBPs, kits for biochemical, hematological, histological and general clinical laboratory tests, as well as drug products.
OJSC "Nizhpharm" (Nizhny Novgorod)
Part of the STADA CIS holding. Production is located on almost 11.5 thousand square meters. meters with workshops for the production of ointments, creams, suppositories, liniments, tablets.
OJSC "Tatkhimfarmpreparaty" (Kazan)
It has two modern plants: a chemical-pharmaceutical plant and a plant for suture-surgical materials. It has production facilities that allow it to annually produce more than 111 types of finished medicines.
OJSC Kurgan "Sintez" (Kurgan)
Production of natural and semi-synthetic antibiotic substances, production of pharmaceutical drugs and honey. plastic products.
CJSC "Evalar" (Altai region, Biysk)
Development and production of natural medicines and parapharmaceuticals
CJSC "Altaivitamins" (Altai Territory, Biysk)
Large manufacturer of medicines, dietary supplements natural basis, fortified food products and cosmeceuticals
JSC "Biosintez" (Penza)
Production of various pharmaceutical products
OJSC "Novosibkhimpharm" (Novosibirsk)
Specializes in the production of injection solutions in ampoules and patches.
LLC NPO "SibEnzim" (Novosibirsk)
Production and sale of nucleic acid metabolic enzymes and related drugs.
JSC "Biokhimik" (Saransk)
Produces more than 60 types of drugs: antibiotics, antitumor agents, plasma replacement solutions, diuretics, drugs used for anesthesia, painkillers
OJSC "Kraspharma" (Krasnoyarsk)
Main products: antibiotics, infusions and blood plasma substitutes
JSC "Organika" (Novokuznetsk)
Release of FPP. The main products are drugs acting on the central nervous system.
JSC "Pharmasintez" (Irkutsk)
The country's largest domestic manufacturer of anti-tuberculosis drugs. Among the top twenty pharmaceutical enterprises in Russia in terms of production volumes
